 | • レポートコード：MRC23Q30089 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2-3日） • 産業分類：電子＆半導体 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の3Dマイクロ流体臓器チップ市場について調査・分析し、世界の3Dマイクロ流体臓器チップ市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（ブレインオンチップ、レバーオンチップ、キドニーオンチップ、その他）、用途別セグメント分析（病院、バイオ、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Emulate、TissUse、Hesperos、CN Bio Innovations、Tara Biosystems、Draper Laboratory、Mimetas、Nortis、Micronit Microtechnologies B.V.、Kirkstall、Cherry Biotech SAS、Else Kooi Laboratoryなどが含まれています。世界の3Dマイクロ流体臓器チップ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争による影響は、3Dマイクロ流体臓器チップ市場規模を推定する際に考慮しました。本レポートは、3Dマイクロ流体臓器チップの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、3Dマイクロ流体臓器チップに関するビジネス上の意思決定に役立てることを目的としています。 ・3Dマイクロ流体臓器チップ市場の概要 - 製品の定義 - 3Dマイクロ流体臓器チップのタイプ別セグメント - 世界の3Dマイクロ流体臓器チップ市場成長率のタイプ別分析（ブレインオンチップ、レバーオンチップ、キドニーオンチップ、その他） - 3Dマイクロ流体臓器チップの用途別セグメント - 世界の3Dマイクロ流体臓器チップ市場成長率の用途別分析（病院、バイオ、その他） - 世界市場の成長展望 - 世界の3Dマイクロ流体臓器チップ生産量の推定と予測（2018年-2029年） - 世界の3Dマイクロ流体臓器チップ生産能力の推定と予測（2018年-2029年） - 3Dマイクロ流体臓器チップの平均価格の推定と予測（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 3Dマイクロ流体臓器チップ市場の競争状況およびトレンド ・3Dマイクロ流体臓器チップの地域別生産量 - 3Dマイクロ流体臓器チップ生産量の地域別推計と予測（2018年-2029年） - 地域別3Dマイクロ流体臓器チップ価格分析（2018年-2023年） - 北米の3Dマイクロ流体臓器チップ生産規模（2018年-2029年） - ヨーロッパの3Dマイクロ流体臓器チップ生産規模（2018年-2029年） - 中国の3Dマイクロ流体臓器チップ生産規模（2018年-2029年） - 日本の3Dマイクロ流体臓器チップ生産規模（2018年-2029年） - 韓国の3Dマイクロ流体臓器チップ生産規模（2018年-2029年） - インドの3Dマイクロ流体臓器チップ生産規模（2018年-2029年） ・3Dマイクロ流体臓器チップの地域別消費量 - 3Dマイクロ流体臓器チップ消費量の地域別推計と予測（2018年-2029年） - 北米の3Dマイクロ流体臓器チップ消費量（2018年-2029年） - アメリカの3Dマイクロ流体臓器チップ消費量（2018年-2029年） - ヨーロッパの3Dマイクロ流体臓器チップ消費量（2018年-2029年） - アジア太平洋の3Dマイクロ流体臓器チップ消費量（2018年-2029年） - 中国の3Dマイクロ流体臓器チップ消費量（2018年-2029年） - 日本の3Dマイクロ流体臓器チップ消費量（2018年-2029年） - 韓国の3Dマイクロ流体臓器チップ消費量（2018年-2029年） - 東南アジアの3Dマイクロ流体臓器チップ消費量（2018年-2029年） - インドの3Dマイクロ流体臓器チップ消費量（2018年-2029年） - 中南米・中東・アフリカの3Dマイクロ流体臓器チップ消費量（2018年-2029年） ・タイプ別セグメント：ブレインオンチップ、レバーオンチップ、キドニーオンチップ、その他 - 世界の3Dマイクロ流体臓器チップのタイプ別生産量（2018年-2023年） - 世界の3Dマイクロ流体臓器チップのタイプ別生産量（2024年-2029年） - 世界の3Dマイクロ流体臓器チップのタイプ別価格 ・用途別セグメント：病院、バイオ、その他 - 世界の3Dマイクロ流体臓器チップの用途別生産量（2018年-2023年） - 世界の3Dマイクロ流体臓器チップの用途別生産量（2024年-2029年） - 世界の3Dマイクロ流体臓器チップの用途別価格 ・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向 Emulate、TissUse、Hesperos、CN Bio Innovations、Tara Biosystems、Draper Laboratory、Mimetas、Nortis、Micronit Microtechnologies B.V.、Kirkstall、Cherry Biotech SAS、Else Kooi Laboratory ・産業チェーンと販売チャネルの分析 - 3Dマイクロ流体臓器チップ産業チェーン分析 - 3Dマイクロ流体臓器チップの主要原材料 - 3Dマイクロ流体臓器チップの販売チャネル - 3Dマイクロ流体臓器チップのディストリビューター - 3Dマイクロ流体臓器チップの主要顧客 ・3Dマイクロ流体臓器チップ市場ダイナミクス - 3Dマイクロ流体臓器チップの業界動向 - 3Dマイクロ流体臓器チップ市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
The global 3D Microfluidic Organ Chip market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for 3D Microfluidic Organ Chip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for 3D Microfluidic Organ Chip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of 3D Microfluidic Organ Chip include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis and Micronit Microtechnologies B.V., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 3D Microfluidic Organ Chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Microfluidic Organ Chip.
The 3D Microfluidic Organ Chip market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global 3D Microfluidic Organ Chip market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Microfluidic Organ Chip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Others
Segment by Application
Hospital
Biotechnology
Others
Production by Region
North America
Europe
China
Japan
South Korea
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 3D Microfluidic Organ Chip manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of 3D Microfluidic Organ Chip by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of 3D Microfluidic Organ Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 3D Microfluidic Organ Chip Market Overview
1.1 Product Definition
1.2 3D Microfluidic Organ Chip Segment by Type
1.2.1 Global 3D Microfluidic Organ Chip Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Others
1.3 3D Microfluidic Organ Chip Segment by Application
1.3.1 Global 3D Microfluidic Organ Chip Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Hospital
1.3.3 Biotechnology
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global 3D Microfluidic Organ Chip Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global 3D Microfluidic Organ Chip Production Estimates and Forecasts (2018-2029)
1.4.4 Global 3D Microfluidic Organ Chip Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global 3D Microfluidic Organ Chip Production Market Share by Manufacturers (2018-2023)
2.2 Global 3D Microfluidic Organ Chip Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of 3D Microfluidic Organ Chip, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global 3D Microfluidic Organ Chip Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global 3D Microfluidic Organ Chip Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of 3D Microfluidic Organ Chip, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of 3D Microfluidic Organ Chip, Product Offered and Application
2.8 Global Key Manufacturers of 3D Microfluidic Organ Chip, Date of Enter into This Industry
2.9 3D Microfluidic Organ Chip Market Competitive Situation and Trends
2.9.1 3D Microfluidic Organ Chip Market Concentration Rate
2.9.2 Global 5 and 10 Largest 3D Microfluidic Organ Chip Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 3D Microfluidic Organ Chip Production by Region
3.1 Global 3D Microfluidic Organ Chip Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global 3D Microfluidic Organ Chip Production Value by Region (2018-2029)
3.2.1 Global 3D Microfluidic Organ Chip Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of 3D Microfluidic Organ Chip by Region (2024-2029)
3.3 Global 3D Microfluidic Organ Chip Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global 3D Microfluidic Organ Chip Production by Region (2018-2029)
3.4.1 Global 3D Microfluidic Organ Chip Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of 3D Microfluidic Organ Chip by Region (2024-2029)
3.5 Global 3D Microfluidic Organ Chip Market Price Analysis by Region (2018-2023)
3.6 Global 3D Microfluidic Organ Chip Production and Value, Year-over-Year Growth
3.6.1 North America 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2018-2029)
3.6.3 China 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2018-2029)
3.6.5 South Korea 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2018-2029)
4 3D Microfluidic Organ Chip Consumption by Region
4.1 Global 3D Microfluidic Organ Chip Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global 3D Microfluidic Organ Chip Consumption by Region (2018-2029)
4.2.1 Global 3D Microfluidic Organ Chip Consumption by Region (2018-2023)
4.2.2 Global 3D Microfluidic Organ Chip Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America 3D Microfluidic Organ Chip Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe 3D Microfluidic Organ Chip Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific 3D Microfluidic Organ Chip Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific 3D Microfluidic Organ Chip Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa 3D Microfluidic Organ Chip Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global 3D Microfluidic Organ Chip Production by Type (2018-2029)
5.1.1 Global 3D Microfluidic Organ Chip Production by Type (2018-2023)
5.1.2 Global 3D Microfluidic Organ Chip Production by Type (2024-2029)
5.1.3 Global 3D Microfluidic Organ Chip Production Market Share by Type (2018-2029)
5.2 Global 3D Microfluidic Organ Chip Production Value by Type (2018-2029)
5.2.1 Global 3D Microfluidic Organ Chip Production Value by Type (2018-2023)
5.2.2 Global 3D Microfluidic Organ Chip Production Value by Type (2024-2029)
5.2.3 Global 3D Microfluidic Organ Chip Production Value Market Share by Type (2018-2029)
5.3 Global 3D Microfluidic Organ Chip Price by Type (2018-2029)
6 Segment by Application
6.1 Global 3D Microfluidic Organ Chip Production by Application (2018-2029)
6.1.1 Global 3D Microfluidic Organ Chip Production by Application (2018-2023)
6.1.2 Global 3D Microfluidic Organ Chip Production by Application (2024-2029)
6.1.3 Global 3D Microfluidic Organ Chip Production Market Share by Application (2018-2029)
6.2 Global 3D Microfluidic Organ Chip Production Value by Application (2018-2029)
6.2.1 Global 3D Microfluidic Organ Chip Production Value by Application (2018-2023)
6.2.2 Global 3D Microfluidic Organ Chip Production Value by Application (2024-2029)
6.2.3 Global 3D Microfluidic Organ Chip Production Value Market Share by Application (2018-2029)
6.3 Global 3D Microfluidic Organ Chip Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Emulate
7.1.1 Emulate 3D Microfluidic Organ Chip Corporation Information
7.1.2 Emulate 3D Microfluidic Organ Chip Product Portfolio
7.1.3 Emulate 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Emulate Main Business and Markets Served
7.1.5 Emulate Recent Developments/Updates
7.2 TissUse
7.2.1 TissUse 3D Microfluidic Organ Chip Corporation Information
7.2.2 TissUse 3D Microfluidic Organ Chip Product Portfolio
7.2.3 TissUse 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.2.4 TissUse Main Business and Markets Served
7.2.5 TissUse Recent Developments/Updates
7.3 Hesperos
7.3.1 Hesperos 3D Microfluidic Organ Chip Corporation Information
7.3.2 Hesperos 3D Microfluidic Organ Chip Product Portfolio
7.3.3 Hesperos 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Hesperos Main Business and Markets Served
7.3.5 Hesperos Recent Developments/Updates
7.4 CN Bio Innovations
7.4.1 CN Bio Innovations 3D Microfluidic Organ Chip Corporation Information
7.4.2 CN Bio Innovations 3D Microfluidic Organ Chip Product Portfolio
7.4.3 CN Bio Innovations 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.4.4 CN Bio Innovations Main Business and Markets Served
7.4.5 CN Bio Innovations Recent Developments/Updates
7.5 Tara Biosystems
7.5.1 Tara Biosystems 3D Microfluidic Organ Chip Corporation Information
7.5.2 Tara Biosystems 3D Microfluidic Organ Chip Product Portfolio
7.5.3 Tara Biosystems 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Tara Biosystems Main Business and Markets Served
7.5.5 Tara Biosystems Recent Developments/Updates
7.6 Draper Laboratory
7.6.1 Draper Laboratory 3D Microfluidic Organ Chip Corporation Information
7.6.2 Draper Laboratory 3D Microfluidic Organ Chip Product Portfolio
7.6.3 Draper Laboratory 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Draper Laboratory Main Business and Markets Served
7.6.5 Draper Laboratory Recent Developments/Updates
7.7 Mimetas
7.7.1 Mimetas 3D Microfluidic Organ Chip Corporation Information
7.7.2 Mimetas 3D Microfluidic Organ Chip Product Portfolio
7.7.3 Mimetas 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Mimetas Main Business and Markets Served
7.7.5 Mimetas Recent Developments/Updates
7.8 Nortis
7.8.1 Nortis 3D Microfluidic Organ Chip Corporation Information
7.8.2 Nortis 3D Microfluidic Organ Chip Product Portfolio
7.8.3 Nortis 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Nortis Main Business and Markets Served
7.7.5 Nortis Recent Developments/Updates
7.9 Micronit Microtechnologies B.V.
7.9.1 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Corporation Information
7.9.2 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Product Portfolio
7.9.3 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Micronit Microtechnologies B.V. Main Business and Markets Served
7.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
7.10 Kirkstall
7.10.1 Kirkstall 3D Microfluidic Organ Chip Corporation Information
7.10.2 Kirkstall 3D Microfluidic Organ Chip Product Portfolio
7.10.3 Kirkstall 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Kirkstall Main Business and Markets Served
7.10.5 Kirkstall Recent Developments/Updates
7.11 Cherry Biotech SAS
7.11.1 Cherry Biotech SAS 3D Microfluidic Organ Chip Corporation Information
7.11.2 Cherry Biotech SAS 3D Microfluidic Organ Chip Product Portfolio
7.11.3 Cherry Biotech SAS 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Cherry Biotech SAS Main Business and Markets Served
7.11.5 Cherry Biotech SAS Recent Developments/Updates
7.12 Else Kooi Laboratory
7.12.1 Else Kooi Laboratory 3D Microfluidic Organ Chip Corporation Information
7.12.2 Else Kooi Laboratory 3D Microfluidic Organ Chip Product Portfolio
7.12.3 Else Kooi Laboratory 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Else Kooi Laboratory Main Business and Markets Served
7.12.5 Else Kooi Laboratory Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 3D Microfluidic Organ Chip Industry Chain Analysis
8.2 3D Microfluidic Organ Chip Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 3D Microfluidic Organ Chip Production Mode & Process
8.4 3D Microfluidic Organ Chip Sales and Marketing
8.4.1 3D Microfluidic Organ Chip Sales Channels
8.4.2 3D Microfluidic Organ Chip Distributors
8.5 3D Microfluidic Organ Chip Customers
9 3D Microfluidic Organ Chip Market Dynamics
9.1 3D Microfluidic Organ Chip Industry Trends
9.2 3D Microfluidic Organ Chip Market Drivers
9.3 3D Microfluidic Organ Chip Market Challenges
9.4 3D Microfluidic Organ Chip Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
